Arterial stiffness and endothelial dysfunction in HIV-infected children

AIDS

Volumn 18, Issue 7, 2004, Pages 1037-1041

  Bonnet, Damien ^a,b   Aggoun, Yacine ^b   Szezepanski, Isabelle ^a   Bellal, Nassima ^a   Blanche, Stéphane ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

Author keywords

Antiretroviral therapy; Endothelium; Paediatrics; Protease inhibitors

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTERY COMPLIANCE; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; AUTOANALYSIS; AUTOMATION; CARDIOVASCULAR RISK; CAROTID ARTERY; CELL DAMAGE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIASTOLE; DYSLIPIDEMIA; ECHOGRAPHY; ENDOTHELIUM; ENDOTHELIUM LESION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTIMA; MALE; PRIORITY JOURNAL; SYSTOLE; YOUNG MODULUS;

ADOLESCENT; ADULT; ANTHROPOMETRY; ANTI-HIV AGENTS; BRACHIAL ARTERY; CAROTID ARTERY, COMMON; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HIV INFECTIONS; HUMANS; MALE; VASCULAR RESISTANCE; VASODILATION;

EID: 2342581610     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200404300-00012     Document Type: Article

References (21)

1. van Rossum AM, Fraaij PL, de Groot R. Efficacy of highly active antiretroviral therapy in HIV-1 infected children. Lancet Infect Dis 2002, 2:93-102.
2. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000, 356:1423-1430.
3. Melvin AJ, Lennon S, Mohan KM, Purnell JQ. Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors. AIDS Res Hum Retroviruses 2001, 17:1117-1123.
4. Lainka E, Oezbek S, Falck M, Ndagijimana J, Niehues T. Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy. Pediatrics 2002, 110:e56. (http://www.pediatrics.org/cgi/content/full/110/5/e56)
5. Jaquet D, Levine M, Ortega-Rodriguez E, Faye A, Polak M, Vilmer E, et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS 2000, 14:2123-2128.
6. Stein JH, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001, 104:257-262.
7. Seminari E, Pan A, Voltini G, Carnevale G, Maserati R, Minoli L, et al. Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. Atherosclerosis 2002, 162:433-438.
8. Mercie P, Thiebaut R, Lavignolle V, Pellegrin JL, Yvorra-Vives MC, Morlat P, et al. Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement. Ann Med 2002, 34:55-63.
9. Chironi G, Escaut L, Gariepy J, Cogny A, Teicher E, Monsuez JJ, et al. Brief report: carotid intima-media thickness in heavily pretreated HIV-infected patients. J Acquir Immune Defic Syndr 2003, 32:490-493.
10. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003, 348:702-710.
11. Sharland M, di Zub GC, Ramos JT, Blanche S, Gibb DM; PENTA Steering Committee. PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. Pediatric European Network for Treatment of AIDS. HIV Med 2002, 3:215-226.
12. Christensen B, Glueck C, Kwiterovich P, Degroot I, Chase G, Heiss G, et al. Plasma cholesterol and triglyceride distributions in 13,665 children and adolescents: the Prevalence Study of the Lipid Research Clinics Program. Pediatr Res 1980, 14:194-202.
13. Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001, 358:1400-1404.
14. Aggoun Y, Bonnet D, Sidi D, Girardet JP, Brucker E, Polak M, et al. Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000, 20:2070-2075.
15. Park SH, Shub C, Nobrega TP, Bailey KR, Seward JB. Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography. J Am Soc Echocardiogr 1996, 9:119-128.
16. Paton P, Tabib A, Loire R, Tete R. Coronary artery lesions and human immunodeficiency virus infection. Res Virol 1993, 144:225-231.
17. Joshi VV, Pawel B, Connor E, Sharer L, Oleske JM, Morrison S, et al. Arteriopathy in children with acquired immune deficiency syndrome. Pediatr Pathol 1987, 7:261-275.
18. Schecter AD, Berman AB, Yi L, Mosoian A, McManus CM, Berman JW, Klotman ME, et al. HIV envelope gp120 activates human arterial smooth muscle cells. Proc Natl Acad Sci USA 2001, 98:10142-10147.
19. Chi D, Henry J, Kelley J, Thorpe R, Smith JK, Krishnaswamy G. The effects of HIV infection on endothelial function. Endothelium 2000, 7:223-242.
20. Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, et al. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P(2)C(2) HIV) Study Group. Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study. Lancet 2002, 360:368-373.
21. Wolf K, Tsakiris DA, Weber R, Erb P, Battegay M, Swiss HIV Cohort Study. Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. J Infect Dis 2002, 185:456-462.